Stockreport

Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS

Biomerica, Inc.  (BMRA) 
NASDAQ:AMEX Investor Relations: biomerica.com/company/investor.asp
PDF Publication details large multicenter clinical trial demonstrating significant reductions in IBS symptoms through inFoods IBS guided dietary therapy IRVINE, Calif., Nov [Read more]